MPS World Summit 2024 in Seattle, WA
Meet SynVivo at MPS World Summit in Seattle Booth #87 Meet us at our booth to learn more about out Organ-on-Chip capabilities Join the Educational Workshop Monday, June 10, 2024…
DetailsAACR 2024 in San Diego, CA
Meet SynVivo at AACR 2024 in San Diego Booth# 117 Meet us at our booth to learn more about out Organ-on-Chip capabilities Poster Presentation Wednesday, April 10, 2024 Session 6:…
DetailsSociety for Toxicology 2024 in Salt Lake City, Utah
Meet SynVivo at Society for Toxicology 2024 in Salt Lake City Booth# 1700 View our schedule and join us at the presentation, posters or meet us at Booth #1700 to…
DetailsSynVivo’s Vessel-on-a-Chip used to study cellular interactions during human blood flow conditions
A new publication in the Journal “Small” reports on the use of SynVivo’s Vessel-on-a-Chip for the study of complex cellular interactions of nanoparticles during human blood flow conditions. See below…
DetailsNew Publications Highlight the Utility of SynVivo’s Inflammation Model to Study Neutrophil-Endothelial Interactions During Sepsis and Inflammation
SynVivo’s Inflammation Model is highlighted in two new publications that report on neutrophil-endothelial interactions and endothelial barrier function during Sepsis and Inflammation. See Download links below. “Experimental Approaches to Evaluate…
DetailsNew Publication Using the SynVivo Platform Describes Air-Liquid Interface (ALI) Model for Human Airway-on-Chip
Researchers from the University of Alabama, Birmingham report on the use of the SynVivo platform for the development of a human airway-on-a chip model which combined with novel micro-optical coherence…
Details
SynVivo for CytoViva – Visualization Of Cell-Nanoparticle Interactions
SynVivo is announcing the availability of a new assay chip designed specifically to provide a long term cell culturing environment compatible with advanced microscopy systems from CytoViva. CytoViva’s technology combines patented,…
DetailsNanotech Drug Delivery Shows Promise For Improved Melanoma Treatment
Researchers at Oregon State University have developed a new three-drug delivery system for cancer treatment, especially metastatic melanoma, the deadliest form of skin cancer – and shown that the system…
DetailsSynVivo Tumor Assay Featured on the Cover of J Controlled Release
We are proud that the editors of the Journal of Controlled Release have selected a new paper from SynVivo CTO, Prabhakar Pandian, Ph.D, and his colleagues as the cover of…
DetailsLeukocyte Rolling, Adhesion, and Migration in a Single Assay!
Leukocytes play a key role in early response to tissue injury/infection resulting from physical, chemical or biological stimuli. This process involves the initiation of the leukocyte adhesion cascade mediated by…
Details